References
- Muramatsu J. A study of effects of CDP-choline (Nicholin) on sequelae of cerebral apoplexy, Manuscript in preparation
- Aizawa T., Mori K., Komi K. Cerebrovascular accidents looked on from the point of view of mitochondrial respiration. Japanese Medical Journal 1971; 2450: 43–47
- Brunnstrom S. Movement therapy in hemiplegia: A neurophysiological approach. Harper & Row, New York 1970
- Furumr K. Studies of brain mitochondria in experimental cerebrovascular accident–with particular reference to the effects of drug therapy. Journal of the Keio Medical Society 1970; 47: 343–357
- Iguchi K., Ono H. Clinical trial of Nicholin in rehabilitation of patients with cerebral apoplexy. Clinical Literature on Nicholin. Takeda Chemical Industries, Osaka 1970; 155–160
- Kameyama M., Ohtomo E., Koshijima S., Kodama R., Ezawa K., Muramatsu M., Yokoyama I., Hirai S., Araki G., Nakahara T., Misumi H. Clinical effects of citicoline (CDP-choline) on sequelae of cerebral apoplexy–a double-blind study. Rinsho Hyoka (Clinical Evaluation) 1974; 2: 429–439
- Kase M., Ono J., Yoshimasu N., Hiyamuta E., Sugiura K., Itoh R., Hamasaki K. Effect of CDP-choline in experimental cerebral hemorrhage. Current Therapeutic Research 1974; 16: 483–502
- Kitajima Y., Koide M., Fukumitsu S., Mimura G., Jinnai T. Clinical application of CDP-choline to patients with cerebrovascular accidents. Journal of New Remedies and Clinics 1968; 17: 775–779
- Miyazaki M. Evaluation of the effectiveness of citicoline (CDP-choline) on motor paralysis as a sequela of cerebral apoplexy. Japanese Journal of Geriatrics 1969; 6: 245–252
- Miyazaki N., Fujishima H. Therapeutic effect of Nicholin in the treatment of sequelae of cerebral apoplexy–a double-blind study. The Japanese Journal of Clinical and Experimental Medicine 1977; 54: 647–662
- Moriyasu N., Koike Y., Murai S., Tsubokawa T. Effects of CDP-choline on the mitochondria of the injured brain. Clinical Literature on Nicholin. Takeda Chemical Industries, Osaka 1971; 1–4
- Muramatsu J., Hirata K., Orita M., Ikita M. Clinical findings with CDP-choline (Nicholin) in the treatment of sequelae of cerebrovascular accident (motor dysfunction). Clinical Literature on Nicholin. Takeda Chemical Industries, Osaka 1971; 28–38
- Nara S., Katoh M., Shigeno K., Saitoh M., Hasegawa T. Effects of Nicholin on rehabilitation of patients with cerebral apoplexy. Clinical Literature on Nicholin. Takeda Chemical Industries, Osaka 1970; 150–154
- Ohhashi R., Takeda S. Effects of Nicholin on sequelae of cerebral apoplexy–comparison of effects of 200 mg/day with those of 500 mg/day of Nicholin. Medicinal Treatment 1970; 3: 121–124
- Sakuma A., Ueda S., Hazama T., Hasegawa T., Kusu-noki T., Kifune Y. A study of standardization of hemiplegia function tests. Japanese Journal of Clinical Pharmacology 1976; 7: 271–308
- Satoh H., Kimura I., Handa Y., Saitoh J., Itoh H. Effects of CDP-choline on various neurologic diseases. Japanese Journal of Clinical and Experimental Medicine 1974; 51: 2256–2260
- Ueda S. Symptomatology and pathophysiology of central paralysis. Japanese Journal of Physical Therapy and Occupational Therapy 1971; 5: 418–428
- Ueda S. Evaluation and treatment of hemiplegia. Proceedings of the 19th Congress of the Japanese Association of Medical Sciences. 1975a; 285–288
- Ueda S. Evaluation of adult hemiplegia. Sogo Rehabilitation (Comprehensive Rehabilitation) 1975b; 3: 717–725
- Ueda S., Fukuma Y., Hazama T., Hasegawa T., Sakuma A. A study of standardization of the hemiplegia function tests. Sogo Rehabilitation (Comprehensive Rehabilitation) 1977; 5: 749–766
- Yoshimoto T., Suzuki J. Basic studies of CDP-choline in monkeys with experimental cerebral circulation failure; limits to the allowance for the blocking of the meddle cerebral artery and its extention. Basic Pharmacology and Therapeutics 1976; 4: 823–829